|
|
ARCH
PHARMA |
|
| NATURE
OF INDUSTRY/ACTIVITY : |
Manufacture
and sale of APIs and Intermediates to innovator
and generic pharmaceutical players |
| ISIN NO : |
INE182F01017
|
| PAID UP EQUITY
CAPITAL : |
25 crore |
| FACE VALUE
: |
Rs 10 per
share |
| PROMOTERS
: |
|
| PROMOTERS
SHARE HOLDING : |
|
| YEAR |
2009-10
2010-11
2011-12 |
| |
|
BOOK VALUE
: (per share)
|
220
274
314 |
| FREE RESERVES
: (in cr) |
415
653
754 |
| TURNOVER :
in rs.cr Unconsolidated : |
1023
1279
1493 |
| NET PROFIT
(PBT) : |
71.47
118
138 |
PROFIT AFTER TAX :
|
50.88
83
101 |
| EPS : |
23
33
40 |
| DIVIDEND : |
0.0
0.0
0.0 |
| SALES : |
|
COMPANY WEBSITE :
|
www.archpharmalabs.com |
| COMPANY BROCHURE : |
DOWNLOAD
BROCHURE |
